BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lv J, Liu C, Chen FK, Feng ZP, Jia L, Liu PJ, Yang ZX, Hou F, Deng ZY. M2‑like tumour‑associated macrophage‑secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway. Mol Med Rep 2021;24:604. [PMID: 34184083 DOI: 10.3892/mmr.2021.12249] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Li C, Dong X, Yuan Q, Xu G, Di Z, Yang Y, Hou J, Zheng L, Chen W, Wu G. Identification of novel characteristic biomarkers and immune infiltration profile for the anaplastic thyroid cancer via machine learning algorithms. J Endocrinol Invest 2023. [PMID: 36725810 DOI: 10.1007/s40618-023-02022-6] [Reference Citation Analysis]
2 Belfiore A, Rapicavoli RV, Le Moli R, Lappano R, Morrione A, De Francesco EM, Vella V. IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? Biomedicines 2023;11. [PMID: 36672737 DOI: 10.3390/biomedicines11010229] [Reference Citation Analysis]
3 Lundeen M, Hurd JL, Hayes M, Hayes M, Facile TR, Furia JP, Maffulli N, Alt C, Alt EU, Schmitz C, Pearce DA. Long-term safety and efficacy of treating symptomatic, partial-thickness rotator cuff tears with fresh, uncultured, unmodified, autologous, adipose-derived regenerative cells isolated at the point of care: 40 months follow-up of a prospective, randomized, controlled, first-in-human clinical trial.. [DOI: 10.1101/2022.12.14.22283447] [Reference Citation Analysis]
4 Kerneur C, Cano CE, Olive D. Major pathways involved in macrophage polarization in cancer. Front Immunol 2022;13:1026954. [DOI: 10.3389/fimmu.2022.1026954] [Reference Citation Analysis]
5 Zheng SM, Chen H, Sha WH, Chen XF, Yin JB, Zhu XB, Zheng ZW, Ma J. Oxidized low-density lipoprotein stimulates CD206 positive macrophages upregulating CD44 and CD133 expression in colorectal cancer with high-fat diet. World J Gastroenterol 2022; 28(34): 4993-5006 [PMID: 36160648 DOI: 10.3748/wjg.v28.i34.4993] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang G, Tao X, Ji B, Gong J, Ciriolo MR. Hypoxia-Driven M2-Polarized Macrophages Facilitate Cancer Aggressiveness and Temozolomide Resistance in Glioblastoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/1614336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nwabo Kamdje AH, Seke Etet PF, Kipanyula MJ, Vecchio L, Tagne Simo R, Njamnshi AK, Lukong KE, Mimche PN. Insulin-like growth factor-1 signaling in the tumor microenvironment: Carcinogenesis, cancer drug resistance, and therapeutic potential. Front Endocrinol 2022;13:927390. [DOI: 10.3389/fendo.2022.927390] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fath MK, Ebrahimi M, Nourbakhsh E, Hazara AZ, Mirzaei A, Shafieyari S, Salehi A, Hoseinzadeh M, Payandeh Z, Barati G. PI3K/Akt/mTOR Signaling Pathway in Cancer Stem Cells. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.154010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Luo S, Yang G, Ye P, Cao N, Chi X, Yang WH, Yan X. Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells. Biomolecules 2022;12:850. [PMID: 35740975 DOI: 10.3390/biom12060850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Liu Q, Sun W, Zhang H. Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer. Front Pharmacol 2022;13:875384. [DOI: 10.3389/fphar.2022.875384] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang S, Yang Y, Ma P, Huang H, Tang Q, Miao H, Fang Y, Jiang N, Li Y, Zhu Q, Tao W, Zha Y, Li N. Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials. Mol Ther Oncolytics 2022;24:799-813. [PMID: 35317518 DOI: 10.1016/j.omto.2022.02.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Matsushita M, Fujita K, Hatano K, De Velasco MA, Uemura H, Nonomura N. Connecting the Dots Between the Gut–IGF-1–Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis. Front Endocrinol 2022;13:852382. [DOI: 10.3389/fendo.2022.852382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liang J, Wang S, Zhang G, He B, Bie Q, Zhang B. A New Antitumor Direction: Tumor-Specific Endothelial Cells. Front Oncol 2021;11:756334. [PMID: 34988011 DOI: 10.3389/fonc.2021.756334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhu X, Wang X, Gong Y, Deng J. E-cadherin on epithelial-mesenchymal transition in thyroid cancer. Cancer Cell Int 2021;21:695. [PMID: 34930256 DOI: 10.1186/s12935-021-02344-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Wang X, Chen Q. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway. BMC Oral Health 2021;21:598. [PMID: 34814915 DOI: 10.1186/s12903-021-01955-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Wu WJ, Wang SH, Wu CC, Su YA, Chiang CY, Lai CH, Wang TH, Cheng TL, Kuo JY, Hsu TC, Lin TH, Lee YJ. IL-4 and IL-13 Promote Proliferation of Mammary Epithelial Cells through STAT6 and IRS-1. Int J Mol Sci 2021;22:12008. [PMID: 34769439 DOI: 10.3390/ijms222112008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]